(NASDAQ: IRMD) Iradimed's forecast annual revenue growth rate of 10.33% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.39%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 58.92%.
Iradimed's revenue in 2025 is $73,242,121.On average, 1 Wall Street analysts forecast IRMD's revenue for 2025 to be $1,027,504,968, with the lowest IRMD revenue forecast at $1,027,504,968, and the highest IRMD revenue forecast at $1,027,504,968.
In 2026, IRMD is forecast to generate $1,258,537,827 in revenue, with the lowest revenue forecast at $1,258,537,827 and the highest revenue forecast at $1,258,537,827.